Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125209) titled 'Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer' on Aug. 7.
Study Type: Observational
Primary Sponsor: University of Wisconsin, Madison
Condition:
Ovarian Cancer
Cognitive Change
Intervention:
Other: Patient Reported Outcomes Assessment
Recruitment Status: Not recruiting
Date of First Enrollment: October 2025
Target Sample Size: 18
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07125209
Published by HT Digital Content Services with permission from Health Daily Digest....